HALEOSLABS vs KOPRAN: Stock Comparison

Haleos Labs Limited vs Kopran Limited

Live data: 22 July 2026, 3:04 PM IST • Source: NSE and company filings

Kopran Limited is the larger company by market capitalisation. Haleos Labs Limited shows a lower P/E, a higher ROE and faster revenue growth, while Kopran Limited shows a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Haleos Labs Limited and Kopran Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, HALEOSLABS is more favourable on 8 of 13 scored metrics and KOPRAN on 5These counts are context-free and are not an overall rating.

Key Differences

Market Cap
KOPRAN is the larger company
₹942 Cr vs ₹484 Cr
P/E Ratio
HALEOSLABS has a lower P/E
27.94x vs 38.28x
P/B Ratio
KOPRAN has a lower P/B
1.86x vs 2.27x
EPS
HALEOSLABS has higher earnings per share
₹57.3 vs ₹3.41
Dividend Yield
KOPRAN has a higher dividend yield
1.59% vs 0.1%
Revenue Growth (TTM YoY)
HALEOSLABS has faster revenue growth
0% vs -3.66%
EPS Growth (TTM YoY)
HALEOSLABS has faster EPS growth
0% vs -71.88%
Qtr Sales Growth
KOPRAN has stronger quarterly sales growth
-3.03% vs -15.7%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricHALEOSLABSKOPRAN
SectorHealthcare
IndustryPharmaceuticals

Price

MetricHALEOSLABSKOPRAN
Live Price₹1,522.4₹206.27
Day Change-3.09%6.56%
Volume28138.55 L
52-Week High₹1,774₹219
52-Week Low₹1,181₹107
Distance from 52W High-14.18%-5.81%

Valuation

MetricHALEOSLABSKOPRAN
Market Cap₹484 Cr₹942 Cr
P/E Ratio27.94x38.28x
P/B Ratio2.27x1.86x
EPS₹57.3₹3.41
Book Value₹706₹107.35
Dividend Yield0.1%1.59%

Growth

MetricHALEOSLABSKOPRAN
Revenue Growth (TTM YoY)0%-3.66%
EPS Growth (TTM YoY)0%-71.88%
Qtr Sales Growth-15.7%-3.03%
Qtr Profit Growth-85.2%-32.9%

Profitability & Leverage

MetricHALEOSLABSKOPRAN
ROE8.44%4.85%
ROCE9.91%9.75%
Net Margin5.33%3.78%
Operating Margin13.4%6.58%
Debt to Equity0.52x0.29x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricHALEOSLABSKOPRAN
Promoter Holding72.11%44.42%
FII Holding0%0.51% 0.06 pp
DII Holding0.31% 0.01 pp0%
Public Holding27.58% 0.02 pp55.06% 0.06 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Haleos Labs Limited and Kopran Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.